Arginine-containing toothpastes for dentin hypersensitivity: Systematic review and meta-analysis

Quintessence International

Volumn 44, Issue 9, 2013, Pages 709-723

  Yan, Boxi ^a   Yi, Jianru ^a   Li, Yu ^a   Chen, Yin ^b   Shi, Zongdao ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Arginine; Dentin sensitivity; GRADE analysis; Meta analysis; Systematic review; Toothpaste

Indexed keywords

ARGININE; DESENSITIZING AGENT; TOOTHPASTE;

CHEMISTRY; DENTIN SENSITIVITY; HUMAN; META ANALYSIS;

ARGININE; DENTIN DESENSITIZING AGENTS; DENTIN SENSITIVITY; HUMANS; TOOTHPASTES;

EID: 84887913411     PISSN: 00336572     EISSN: None     Source Type: Journal    
DOI: 10.3290/j.qi.a30177     Document Type: Article

References (54)

1. Porto IC, Andrade AK, Montes MA. Diagnosis and treatment of dentinal hypersensitivity. J Oral Sci 2009;51:323-332.
2. Markowitz K, Pashley DH. Personal reflections on a sensitive subject. J Dent Res 2007;86:292-295.
3. Taani DQ, Awartani F. Prevalence and distribution of dentin hypersensitivity and plaque in a dental hospital population. Quintessence Int 2001;32:372-376.
4. Banoczy J. Dentine hypersensitivity. General considerations for successful practice management. Int Dent J 2002;52(Suppl):366.
5. Orchardson R, Gillam DG. Managing dentin hypersensitivity. J Am Dent Assoc 2006;137:990-998.
6. Bartold PM. Dentinal hypersensitivity: a review. Aust Dent J 2006;51:212-218.
7. Bekes K, John MT, Schaller HG, Hirsch C. Oral healthrelated quality of life in patients seeking care for dentin hypersensitivity. J Oral Rehabil 2009;36:45-51.
8. Brannstrom M, Linden LA, Astrom A. The hydrodynamics of the dental tubule and of pulp fluid. A discussion of its significance in relation to dentinal sensitivity. Caries Res 1967;1:310-317.
9. Holland GR, Narhi MN, Addy M, Gangarosa L, Orchardson R. Guidelines for the design and conduct of clinical trials on dentine hypersensitivity. J Clin Periodontol 1997;24:808-813.
10. Dababneh RH, Khouri AT, Addy M. Dentine hypersensitivity:an enigma? A review of terminology, mechanisms, aetiology and management. Br Dent J 1999;187:606-611.
11. Canadian Advisory Board on Dentin Hypersensitivity. Consensus-based recommendations for the diagnosis and management of dentin hypersensitivity. J Can Dent Assoc 2003;69:221-226.
12. Cunha-Cruz J, Wataha JC, Zhou L, Manning W, Trantow M, Bettendorf MM, et al. Treating dentin hypersensitivity:therapeutic choices made by dentists of the northwest PRECEDENT network. J Am Dent Assoc 2010;141:1097-1105.
13. Kerns DG, Scheidt MJ, Pashley DH, Horner JA, Strong SL, Van Dyke TE. Dentinal tubule occlusion and root hypersensitivity. J Periodontol 1991;62:421-428.
14. Kleinberg I. SensiStat. A new saliva-based composition for simple and effective treatment of dentinal sensitivity pain. Dent Today 2002;21:42-47.
15. Lavender SA, Petrou I, Heu R, et al. Mode of action studies on a new desensitizing dentifrice containing 8.0% arginine, a high cleaning calcium carbonate system and 1450 ppm fluoride. Am J Dent 2010;23(Spec No A):14A-19A.
16. Petrou I, Heu R, Stranick M, et al. A breakthrough therapy for dentin hypersensitivity: how dental products containing 8% arginine and calcium carbonate work to deliver effective relief of sensitive teeth. J Clin Dent 2009;20:23-31.
17. Markowitz K. A new treatment alternative for sensitive teeth: a desensitizing oral rinse. J Dent 2013;41(Suppl1):S1-11.
18. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and metaanalyses:the PRISMA statement. PLoS Med 2009;6:e1000097.
19. Higgins JPT, Green S (eds). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
20. Sterne JAC, Egger M, Moher D. Addressing Reporting Biases. In: Higgins JPT, Green S (eds). Cochrane Handbook for Systematic Review of Interventions. Chichester: John Wiley & Sons, 2008:128-150.
21. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088-1101.
22. Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. Br Med J 2004;328:1490.
23. Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines:1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 2011;64:383-394.
24. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. Br Med J 2008;336:924-926.
25. GRADEpro. [Computer program]. Version 3.2 for Windows. Jan Brozek, Andrew Oxman, Holger Schünemann, 2008.
26. Schiff T, Mateo LR, Delgado E, Cummins D, Zhang YP, DeVizio W. Clinical efficacy in reducing dentin hypersensitivity of a dentifrice containing 8.0% arginine, calcium carbonate, and 1450 ppm fluoride compared to a dentifrice containing 8% strontium acetate and 1040 ppm fluoride under consumer usage conditions before and after switch-over. J Clin Dent 2011;22:128-138.
27. Docimo R, Perugia C, Bartolino M, et al. Comparative evaluation of the efficacy of three commercially available toothpastes on dentin hypersensitivity reduction: an eight-week clinical study. J Clin Dent 2011;22:121-127.
28. Li Y, Lee S, Zhang YP, Delgado E, DeVizio W, Matco LR. Comparison of clinical efficacy of three toothpastes in reducing dentin hypersensitivity. J Clin Dent 2011;22:113-120.
29. Ayad F, Ayad N, Delgado E, et al. Comparing the efficacy in providing instant relief of dentin hypersensitivity of a new toothpaste containing 8.0% arginine, calcium carbonate, and 1450 ppm fluoride to a benchmark desensitizing toothpaste containing 2% potassium ion and 1450 ppm fluoride, and to a control toothpaste with 1450 ppm fluoride: a three-day clinical study in Mississauga, Canada. J Clin Dent 2009;20:115-122.
30. Ayad F, Ayad N, Zhang YP, DeVizio W, Cummins D, Mateo LR. Comparing the efficacy in reducing dentin hypersensitivity of a new toothpaste containing 8.0% arginine, calcium carbonate, and 1450 ppm fluoride to a commercial sensitive toothpaste containing 2% potassium ion: an eight-week clinical study on Canadian adults. J Clin Dent 2009;20:10-16.
31. Docimo R, Montesani L, Maturo P, et al. Comparing the efficacy in reducing dentin hypersensitivity of a new toothpaste containing 8.0% arginine, calcium carbonate, and 1450 ppm fluoride to a commercial sensitive toothpaste containing 2% potassium ion:an eight-week clinical study in Rome, Italy. J Clin Dent 2009;20:17-22.
32. Docimo R, Montesani L, Maturo P, et al. Comparing the efficacy in reducing dentin hypersensitivity of a new toothpaste containing 8.0% arginine, calcium carbonate, and 1450 ppm fluoride to a benchmark commercial desensitizing toothpaste containing 2% potassium ion: an eight-week clinical study in Rome, Italy. J Clin Dent 2009;20:137-143.
33. Fu Y, Li X, Que K, et al. Instant dentin hypersensitivity relief of a new desensitizing dentifrice containing 8.0% arginine, a high cleaning calcium carbonate system and 1450 ppm fluoride: a 3-day clinical study in Chengdu, China. Am J Dent 2010;23(Spec No A):20A-27A.
34. Hamlin D, Williams KP, Delgado E, Zhang YP, DeVizio W, Mateo LR. Clinical evaluation of the efficacy of a desensitizing paste containing 8% arginine and calcium carbonate for the in-office relief of dentin hypersensitivity associated with dental prophylaxis. Am J Dent 2009;22(Spec No A):16A-20A.
35. He T, Chang J, Cheng R, Li X, Sun L, Biesbrock AR. Clinical evaluation of the fast onset and sustained sensitivity relief of a 0.454% stannous fluoride dentifrice compared to an 8.0% arginine-calcium carbonate- sodium monofluorophosphate dentifrice. Am J Dent 2011;24:336-340.
36. He T, Cheng R, Biesbrock AR, Chang A, Sun L. Rapid desensitizing efficacy of a stannous-containing sodium fluoride dentifrice. J Clin Dent 2011;22:40-45.
37. Hughes N, Mason S, Jeffery P, et al. A comparative clinical study investigating the efficacy of a test dentifrice containing 8% strontium acetate and 1040 ppm sodium fluoride versus a marketed control dentifrice containing 8% arginine, calcium carbonate, and 1450 ppm sodium monofluorophosphate in reducing dentinal hypersensitivity. J Clin Dent 2010;21:49-55.
38. Nathoo S, Delgado E, Zhang YP, DeVizio W, Cummins D, Mateo LR. Comparing the efficacy in providing instant relief of dentin hypersensitivity of a new toothpaste containing 8.0% arginine, calcium carbonate, and 1450 ppm fluoride relative to a benchmark desensitizing toothpaste containing 2% potassium ion and 1450 ppm fluoride, and to a control toothpaste with 1450 ppm fluoride: a threeday clinical study in New Jersey, USA. J Clin Dent 2009;20:123-130.
39. Que K, Fu Y, Lin L, et al. Dentin hypersensitivity reduction of a new toothpaste containing 8.0% arginine and 1450 ppm fluoride: an 8-week clinical study on Chinese adults. Am J Dent 2010;23(Spec No A):28A-35A.
40. Schiff T, Delgado E, Zhang YP, Cummins D, DeVizio W, Mateo LR. Clinical evaluation of the efficacy of an in-office desensitizing paste containing 8% arginine and calcium carbonate in providing instant and lasting relief of dentin hypersensitivity. Am J Dent 2009;22(Spec No A):8A-15A.
41. Cummins D. Dentin hypersensitivity: from diagnosis to a breakthrough therapy for everyday sensitivity relief. J Clin Dent 2009;20:1-9.
42. Kakar A, Kakar K, Sreenivasan PK, DeVizio W, Kohli R. Comparison of the clinical efficacy of a new dentifrice containing 8.0% arginine, calcium carbonate, and 1000 ppm fluoride to a commercially available sensitive toothpaste containing 2% potassium ion on dentin hypersensitivity: a randomized clinical trial. J Clin Dent 2012;23:40-47.
43. Kakar A, Kakar K, Sreenivasan PK, DeVizio W, Kohli R. Comparison of the clinical efficacy in reducing dentin hypersensitivity of a new dentifrice containing 8.0% arginine, calcium carbonate, and 1000 ppm sodium monofluorophosphate to a commercially available toothpaste containing 1000 ppm sodium monofluorophosphate: an eight-week clinical trial on adults in New Delhi, India. J Clin Dent 2012;23:33-39.
44. Poulsen S, Errboe M, Lescay Mevil Y, Glenny AM. Potassium containing toothpastes for dentine hypersensitivity. Cochrane Database Syst Rev 2006:CD001476.
45. Sgolastra F, Petrucci A, Gatto R, Monaco A. Effectiveness of laser in dentinal hypersensitivity treatment:a systematic review. J Endod 2011;37:297-303.
46. Cunha-Cruz J, Stout JR, Heaton LJ, Wataha JC. Dentin hypersensitivity and oxalates: a systematic review. J Dent Res 2011;90:304-310.
47. Dixon KE, Thorn BE, Ward LC. An evaluation of sex differences in psychological and physiological responses to experimentally-induced pain: a path analytic description. Pain 2004;112:188-196.
48. Lutins ND, Greco GW, McFall WT Jr. Effectiveness of sodium fluoride on tooth hypersensitivity with and without iontophoresis. J Periodontol 1984;55:285-288.
49. McBride MA, Gilpatrick RO, Fowler WL. The effectiveness of sodium fluoride iontophoresis in patients with sensitive teeth. Quintessence Int 1991;22:637-640.
50. Wandner LD, Scipio CD, Hirsh AT, Torres CA, Robinson ME. The perception of pain in others: how gender, race, and age influence pain expectations. J Pain 2012;13:220-227.
51. Knottnerus JA, Tugwell P. Real world research. J Clin Epidemiol 2010;63:1051-1052.
52. Pradeep AR, Sharma A. Comparison of clinical efficacy of a dentifrice containing calcium sodium phosphosilicate to a dentifrice containing potassium nitrate and to a placebo on dentinal hypersensitivity:a randomized clinical trial. J Periodontol 2010;81:1167-1173.
53. Sharma N, Roy S, Kakar A, Greenspan DC, Scott R. A clinical study comparing oral formulations containing 7.5% calcium sodium phosphosilicate (Nova-Min), 5% potassium nitrate, and 0.4% stannous fluoride for the management of dentin hypersensitivity. J Clin Dent 2010;21:88-92.
54. Wefel JS. NovaMin: likely clinical success. Adv Dent Res 2009;21:40-43.